Prescription sleeping pills, insomnia, and suicidality in the national comorbidity survey replication

Journal of Clinical Psychiatry

Volumn 72, Issue 4, 2011, Pages 515-521

  Brower, Kirk J ^a   McCammon, Ryan J ^a,b   Wojnar, Marcin ^a,c   Ilgen, Mark A ^a,b   Wojnar, Julita ^a   Valenstein, Marcia ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VA Serious Mental Illness Treatment Research and Evaluation Center   (United States)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; HYPNOTIC SEDATIVE AGENT; UNCLASSIFIED DRUG; ZALEPLON; ZOLPIDEM; ZOLPIDEM TARTRATE; ZONATA;

ADULT; ARTICLE; CHRONIC DISEASE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HOUSEHOLD; HUMAN; INSOMNIA; INTERVIEW; MALE; MENTAL DISEASE; PRESCRIPTION; PRIORITY JOURNAL; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; UNITED STATES;

ADOLESCENT; ADULT; COMORBIDITY; FEMALE; HEALTH SURVEYS; HUMANS; HYPNOTICS AND SEDATIVES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PRESCRIPTION DRUGS; RISK FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUICIDAL IDEATION; SUICIDE, ATTEMPTED; UNITED STATES; YOUNG ADULT;

EID: 79952670420     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05484gry     Document Type: Article

References (64)

1. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network, 2006: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: DHHS Publication No. (SMA) 08-4339; 2008.
2. Weir P, Ardagh M. The epidemiology of deliberate self poisoning presenting to Christchurch Hospital Emergency Department. N Z Med J. 1998;111(1063):127-129.
3. Buckley NA, McManus PR. Changes in fatalities due to overdose of anxiolytic and sedative drugs in the UK (1983-1999). Drug Saf. 2004; 27(2):135-141. (Pubitemid 38186954)
4. Carlsten A, Waern M, Holmgren P, et al. The role of benzodiazepines in elderly suicides. Scand J Public Health. 2003;31(3):224-228. (Pubitemid 40990820)
5. Mendelson WB, Rich CL. Sedatives and suicide: the San Diego study. Acta Psychiatr Scand. 1993;88(5):337-341. (Pubitemid 23337558)
6. Voaklander DC, Rowe BH, Dryden DM, et al. Medical illness, medication use and suicide in seniors: a population-based case-control study. J Epidemiol Community Health. 2008;62(2):138-146. (Pubitemid 351196854)
7. Allgulander C, Näsman P. Regular hypnotic drug treatment in a sample of 32,679 Swedes: associations with somatic and mental health, inpatient psychiatric diagnoses and suicide, derived with automated record- linkage. Psychosom Med. 1991;53(1):101-108.
8. Rasu RS, Shenolikar RA, Nahata MC, et al. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001. Clin Ther. 2005;27(12):1970-1979. (Pubitemid 43293219)
9. Bertolote JM, Fleischmann A, De Leo D, et al. Psychiatric diagnoses and suicide: revisiting the evidence. Crisis. 2004;25(4):147-155. (Pubitemid 39556511)
10. Harris EC, Barraclough B. Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry. 1997;170(3):205-228. (Pubitemid 27117683)
11. Stepanski EJ, Rybarczyk B. Emerging research on the treatment and etiology of secondary or comorbid insomnia. Sleep Med Rev. 2006;10(1):7-18. (Pubitemid 43106848)
12. Wojnar M, Ilgen MA, Wojnar J, et al. Sleep problems and suicidality in the National Comorbidity Survey Replication. J Psychiatr Res. 2009;43(5): 526-531.
13. Turvey CL, Conwell Y, Jones MP, et al. Risk factors for late-life suicide: a prospective, community-based study. Am J Geriatr Psychiatry. 2002;10(4): 398-406. (Pubitemid 34743344)
14. Liu X. Sleep and adolescent suicidal behavior. Sleep. 2004;27(7): 1351-1358. (Pubitemid 44138902)
15. Goldstein TR, Bridge JA, Brent DA. Sleep disturbance preceding completed suicide in adolescents. J Consult Clin Psychol. 2008;76(1):84-91. (Pubitemid 351215332)
16. Kripke DF, Klauber MR, Wingard DL, et al. Mortality hazard associated with prescription hypnotics. Biol Psychiatry. 1998;43(9):687-693. (Pubitemid 28222390)
17. Mallon L, Broman JE, Hetta J. Is usage of hypnotics associated with mortality? Sleep Med. 2009;10(3):279-286.
18. Neutel CI, Patten SB. Risk of suicide attempts after benzodiazepine and/or antidepressant use. Ann Epidemiol. 1997;7(8):568-574. (Pubitemid 27524370)
19. Goodwin RD, Hasin DS. Sedative use and misuse in the United States. Addiction. 2002;97(5):555-562. (Pubitemid 34492749)
20. Sanger DJ. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs. 2004; 18(suppl 1):9-15, discussion 41, 43-45. (Pubitemid 38626399)
21. Siriwardena AN, Qureshi MZ, Dyas JV, et al. Magic bullets for insomnia? patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. Br J Gen Pract. 2008;58(551):417-422. (Pubitemid 351780899)
22. Borges G, Angst J, Nock MK, et al. A risk index for 12-month suicide attempts in the National Comorbidity Survey Replication (NCS-R). Psychol Med. 2006;36(12):1747-1757. (Pubitemid 44824736)
23. Nock MK, Hwang I, Sampson NA, et al. Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication [published online ahead of print March 31, 2009]. Mol Psychiatry.
24. Roth T, Jaeger S, Jin R, et al. Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication. Biol Psychiatry. 2006;60(12):1364-1371. (Pubitemid 44838536)
25. Kessler RC, Berglund P, Chiu WT, et al. The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res. 2004;13(2):69-92. (Pubitemid 39199022)
26. Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004;13(2):93-121.
27. Lekka NP, Paschalis C, Beratis S. Suicide attempts in high-dose benzodiazepine users. Compr Psychiatry. 2002;43(6):438-442. (Pubitemid 35375519)
28. Marzuk PM, Leon AC, Tardiff K, et al. The effect of access to lethal methods of injury on suicide rates. Arch Gen Psychiatry. 1992;49(6):451-458.
29. Cantor CH, Baume PJ. Access to methods of suicide: what impact? Aust N Z J Psychiatry. 1998;32(1):8-14. (Pubitemid 28163912)
30. Forrester MB. Eszopiclone ingestions reported to Texas poison control centers, 2005 2006. Hum Exp Toxicol. 2007;26(10):795-800. (Pubitemid 350221394)
31. Isacsson G, Holmgren P, Druid H, et al. Psychotropics and suicide prevention. Implications from toxicological screening of 5281 suicides in Sweden 1992-1994. Br J Psychiatry. 1999;174(3):259-265. (Pubitemid 29147243)
32. Lecrubier Y. Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies. J Clin Psychiatry. 2007;68(suppl 2):36-41. (Pubitemid 46333565)
33. Hall RC, Platt DE, Hall RC. Suicide risk assessment: a review of risk factors for suicide in 100 patients who made severe suicide attempts: evaluation of suicide risk in a time of managed care. Psychosomatics. 1999;40(1):18-27. (Pubitemid 29056576)
34. Chellappa SL, Araujo JF. Sleep disorders and suicidal ideation in patients with depressive disorder. Psychiatry Res. 2007;153(2):131-136. (Pubitemid 47539588)
35. Aǧargün MY, Kara H, Solmaz M. Sleep disturbances and suicidal behavior in patients with major depression. J Clin Psychiatry. 1997;58(6):249-251. (Pubitemid 27318559)
36. Agargun MY, Besiroglu L, Cilli AS, et al. Nightmares, suicide attempts, and melancholic features in patients with unipolar major depression. J Affect Disord. 2007;98(3):267-270. (Pubitemid 46149061)
37. Nrugham L, Larsson B, Sund AM. Specific depressive symptoms and disorders as associates and predictors of suicidal acts across adolescence. J Affect Disord. 2008;111(1):83-93.
38. Fawcett J, Scheftner WA, Fogg L, et al Time-related predictors of suicide in major affective disorder. Am J Psychiatry. 1990;147(9):1189-1194. (Pubitemid 20275373)
39. McGirr A, Renaud J, Seguin M, et al. An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study. J Affect Disord. 2007;97(1-3): 203-209. (Pubitemid 44937433)
40. Tanskanen A, Tuomilehto J, Viinamaki H, et al. Nightmares as predictors of suicide. Sleep. 2001;24(7):844-847. (Pubitemid 32979739)
41. Bernert RA, Joiner TEJ Jr, Cukrowicz KC, et al. Suicidality and sleep disturbances. Sleep. 2005;28(9):1135-1141. (Pubitemid 41279511)
42. Sjöström N, Waern M, Hetta J. Nightmares and sleep disturbances in relation to suicidality in suicide attempters. Sleep. 2007;30(1):91-95. (Pubitemid 46095386)
43. Kripke DF. Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry. 2007;7(1):42.
44. Youssef NA, Rich CL. Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? a literature review. Ann Clin Psychiatry. 2008;20(3):157-169. (Pubitemid 352009281)
45. Smith BD, Salzman C. Do benzodiazepines cause depression? Hosp Community Psychiatry. 1991;42(11):1101-1102.
46. Johnson DA. The use of benzodiazepines in depression. Br J Clin Pharmacol. 1985;19(suppl 1):31S-35S. (Pubitemid 16217820)
47. Birkenhäger TK, Moleman P, Nolen WA. Benzodiazepines for depression? a review of the literature. Int Clin Psychopharmacol. 1995;10(3):181-195.
48. Jonas JM, Hearron AE Jr. Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression. J Clin Psychopharmacol. 1996;16(3):208-211. (Pubitemid 26227917)
49. Kripke DF. Chronic hypnotic use: deadly risks, doubtful benefit. Sleep Med Rev. 2000;4(1):5-20. (Pubitemid 30187040)
50. Posternak MA, Mueller TI. Assessing the risks and benefits of benzodiaz-epines for anxiety disorders in patients with a history of substance abuse or dependence. Am J Addict. 2001;10(1):48-68.. (Pubitemid 32201733)
51. Glass J, Lanctôt KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005; 331(7526):1169.
52. Berman ME, Jones GD, McCloskey MS. The effects of diazepam on human self-aggressive behavior. Psychopharmacology (Berl). 2005; 178(1):100-106. (Pubitemid 40298697)
53. Bramness JG, Skurtveit S, Mørland J. Flunitrazepam: psychomotor impairment, agitation and paradoxical reactions. Forensic Sci Int. 2006; 159(2-3):83-91.
54. Rothschild AJ, Shindul-Rothschild, Viguera A, et al. Comparison of the frequency of behavioral disinhibition on alprazolam, clonaze- pam, or no benzodiazepine in hospitalized psychiatric patients. J Clin Psychopharmacol. 2000;20(1):7-11. (Pubitemid 30056347)
55. Dietch JT, Jennings RK. Aggressive dyscontrol in patients treated with benzodiazepines. J Clin Psychiatry. 1988;49(5):184-188.
56. Bond AJ, Curran HV, Bruce MS, et al. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam. J Affect Disord. 1995; 35(3):117-123.
57. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypro-mine. Arch Gen Psychiatry. 1988;45(2):111-119. (Pubitemid 18052841)
58. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
59. Gaertner I, Gilot C, Heidrich P, et al. A case control study on psychopharmacotherapy before suicide committed by 61 psychiatric inpatients. Pharmacopsychiatry. 2002;35(2):37-43. (Pubitemid 34293231)
60. Hajak G, Müller WE, Wittchen HU, et al. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction. 2003;98(10):1371-1378. (Pubitemid 37297243)
61. Victorri-Vigneau C, Dailly E, Veyrac G, et al. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol. 2007;64(2):198-209. (Pubitemid 47063241)
62. Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry. 2005;66(suppl 9):31-41. (Pubitemid 43011561)
63. Neale G, Smith AJ. Self-harm and suicide associated with benzodiazepine usage. Br J Gen Pract. 2007;57(538):407-408. (Pubitemid 46759942)
64. American Psychiatric Association. Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors. Am J Psychiatry. 2003; 160(suppl 11):1-60.